These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 5331452)
21. Suppression of the antibody response to sulfolipids in leprosy patients by 4,4'-diaminodiphenyl sulfone (DDS). Malik U; Khuller GK; Kumar B Antonie Van Leeuwenhoek; 1983 Dec; 49(6):579-83. PubMed ID: 6370132 [TBL] [Abstract][Full Text] [Related]
22. Drug resistance of Mycobacterium leprae, particularly to DDS. Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566 [No Abstract] [Full Text] [Related]
25. Dapsone-resistant leprosy and its implications for leprosy control programmes. Pearson JM; Cap JA; Haile GS; Rees RJ Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000 [No Abstract] [Full Text] [Related]
26. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae. Levy L; Shepard CC; Fasal P Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496 [No Abstract] [Full Text] [Related]
27. The association of pregnancy and leprosy. II. Pregnancy in dapsone-resistant leprosy. Duncan ME; Pearson JM; Rees RJ Lepr Rev; 1981 Sep; 52(3):263-70. PubMed ID: 7035779 [No Abstract] [Full Text] [Related]
28. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action. Holmes IB; Hilson GR J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734 [No Abstract] [Full Text] [Related]
29. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714 [No Abstract] [Full Text] [Related]
30. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene. Karat AB Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966 [No Abstract] [Full Text] [Related]
31. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone. Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440 [TBL] [Abstract][Full Text] [Related]
32. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852 [No Abstract] [Full Text] [Related]
33. Activity of repository sulfones against Mycobacterium leprae in mice. Shepard CC Proc Soc Exp Biol Med; 1967 Feb; 124(2):430-3. PubMed ID: 5335647 [No Abstract] [Full Text] [Related]
34. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]